Mar 5, 2019 | News, Press Release
Astellas Pharma has teamed up with ReForm Biologics to reduce the viscosity of its clinical-phase biologics. The collaboration will leverage excipients ReForm developed to enable the subcutaneous and device-assisted delivery of large molecules. The project builds on...
Mar 5, 2019 | News, Press Release
Astellas Pharma (OTCPK:ALPMY +0.9%) will collaborate with Woburn, MA-based ReForm Biologics on reformulating its pipeline of biologic therapies to allow for alternative dosing, specifically subcutaneous injection, more efficient manufacturing and longer product life...
Mar 5, 2019 | News, Press Release
WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a collaboration with Astellas Pharma Inc. (TSE:...
